Efficient and Selective Prevention of GVHD by Antigen-Specific Induced Tregs via Linked-Suppression in Mice
Open Access
- 31 March 2011
- journal article
- research article
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 17 (3), 309-318
- https://doi.org/10.1016/j.bbmt.2010.12.710
Abstract
No abstract availableKeywords
Funding Information
- NIH (CA 118116, CA143812, AI 51693)
- New Investigator Award supported by ASBMT
This publication has 48 references indexed in Scilit:
- In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemiaBlood, 2010
- Natural and Adaptive Foxp3+ Regulatory T Cells: More of the Same or a Division of Labor?Immunity, 2009
- Human T Regulatory Cell Therapy: Take a Billion or So and Call Me in the MorningImmunity, 2009
- Retinoic Acid Enhances Foxp3 Induction Indirectly by Relieving Inhibition from CD4+CD44hi CellsImmunity, 2008
- In vivo–activated CD103+CD4+ regulatory T cells ameliorate ongoing chronic graft-versus-host diseaseBlood, 2008
- β2 integrins separate graft-versus-host disease and graft-versus-leukemia effectsBlood, 2008
- Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytesNature Medicine, 2007
- Induction of FOXP3 expression in naive human CD4+FOXP3− T cells by T-cell receptor stimulation is transforming growth factor-β–dependent but does not confer a regulatory phenotypeBlood, 2007
- Dendritic cells with TGF-β1 differentiate naïve CD4+CD25−T cells into islet-protective Foxp3+regulatory T cellsProceedings of the National Academy of Sciences of the United States of America, 2007
- Epigenetic Control of the foxp3 Locus in Regulatory T CellsPLoS Biology, 2007